MedPath

Kneehab® pre and post total knee replacement surgery

Not Applicable
Completed
Conditions
Patients undergoing total knee replacement surgery
Surgery
Registration Number
ISRCTN89785408
Lead Sponsor
The Royal Liverpool & Broadgreen University Hospital (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Individuals who are scheduled for Total Knee Replacement surgery
2. Individuals who are at least 18 years of age
3. Individuals with a body mass index (BMI) <35
4. Individuals who are walking independently with or without assistive devices
5. Must be able and willing to complete all study assessments and to be followed for the full course of the study
6. Must be able to read, write and follow instructions in English
7. Must be able and willing to provide informed consent
8. Must be willing and able to attend the additional pre-op assessment

Exclusion Criteria

1. Individuals who have failed the pre-Total Knee Arthroplasty (TKA) operative assessment
2. Individuals with a history of foot and/or ankle pathology
3. Individuals with a history of tibial or femoral fractures
4. Individuals with a history of any underlying neurological conditions
5. Individuals with physical conditions which would make them unable to perform study procedures
6. Individuals with a total hip replacement
7. Individuals undergoing revision TKA of the same operated leg
8. Pregnant women or inadequate precautions to prevent pregnancy
9. Diagnosis of a medical condition that would contraindicate treatment with the product, e.g. skin lesions at electrode site
10. Individuals with an active implanted medical device (i.e. pacemaker, pump)
11. Individuals with a history of stroke
12. Individuals with a history of neurological disorder that affects lower extremity function (stroke, peripheral neuropathy, Parkinson?s disease, multiple sclerosis, etc.)
13. Individuals with a diagnosis of inflammatory arthritis (rheumatoid arthritis, gout or psoriatic arthritis)
14. Individuals with muscle diseases (i.e. muscular dystrophy)
15. Visible skin injury or disease on their legs
16. Principal investigator for this study, or member of study staff

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath